A retrospective cohort study of the efficacy and safety of oral azvudine versus nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years
aDepartment of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
bDepartment of Infectious Diseases, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
cDepartment of Liver Disease, the Affiliated Infectious Disease Hospital of Zhengzhou University, Zhengzhou 450052, China
dGuangshan County People's Hospital, Guangshan County, Xinyang 465450, China
eHenan Center for Disease Control and Prevention, Zhengzhou 450016, China
fXiangya Medical College, Central South University, Changsha 410028, China
gDepartment of Medical Information, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
hDepartment of Infectious Diseases, Shangqiu Municipal Hospital, Shangqiu 476000, China
iDepartment of Infectious Diseases, Luoyang Central Hospital Affiliated of Zhengzhou University, Luoyang 471000, China
jDepartment of Clinical Laboratory, Henan Provincial Chest Hospital Affiliated of Zhengzhou University, Zhengzhou 450008, China
kDepartment of Gastrointestinal Surgery, Nanyang Central Hospital, Nanyang 473009, China
lDepartment of Infectious Diseases, Anyang City Fifth People's Hospital, Anyang 455000, China
mDepartment of Respiratory and Critical Care Medicine, Fengqiu County People's Hospital, Xinxiang 453300, China
nHenan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou University, Zhengzhou 450052, China
oState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
* Corresponding authors.
收起